Good announcement. Win win for so many areas.
I wonder if this real world use case, it's data gathered and experience realised for all will help with evidence to respond to ongoing FDA denovo discussions?
Ann: ResAppDx-EU in Use at COVID-19 Respiratory Clinic, page-29
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #